Research in other monogenic diseases such as muscular dystrophy indicates that even a partial functional rescue of the mutated protein confers patient clinical benefit,112 but such a demonstration has so far only been carried out in vitro for NF1.113 This is due to the fact that NF1 is one of the largest genes and its manipulation into expression vectors has proved very challenging. This evidence concerns the gene NF1 and muscular dystrophy.